HealthTree Foundation Introduces AI-Driven Treatment Options Finder for Blood Cancer Patients

HealthTree Foundation's Innovative AI-Powered Treatment Options Finder

In a significant move for blood cancer treatment accessibility and personalization, the HealthTree Foundation has unveiled its AI-powered Treatment Options Finder. This tool, integrated within the HealthTree Cure Hub, aims to empower patients and their healthcare teams by clearly presenting available therapies tailored to individual patient profiles at every stage of their disease.

Navigating treatment options can be an arduous process for patients grappling with blood cancer. Many find themselves overwhelmed by a plethora of choices without the necessary insights to determine which options best suit their unique conditions. The Treatment Options Finder simplifies this complexity by organizing treatment information into a user-friendly format. Patients can easily access therapies that are pertinent to their specific type of blood cancer, the stage of their illness, and their treatment history.

Utilizing a combination of real-world patient data, validated FDA and National Comprehensive Cancer Network (NCCN) guidelines, alongside cutting-edge research findings, the AI technology embedded in the Treatment Options Finder enables patients to engage effectively with their doctors. This not only aids in informed decision-making but also fosters productive discussions about care options.

Jenny Ahlstrom, Founder and CEO of HealthTree Foundation, emphasized the emotional toll that treatment decision-making can impose on patients. “Making treatment decisions can be one of the most stressful moments in a blood cancer patient's journey,” she stated. “With the Treatment Options Finder, patients can clearly see what personalized therapies are available and feel more confident walking into their next doctor's appointment for shared decision-making.”

Adding to this sentiment, Juan Pablo Capdevila, CTO at HealthTree Foundation, remarked on the ease the tool brings to a traditionally challenging process. “We’re harnessing AI and clean patient data to simplify a very complex process,” he explained. “This tool doesn’t just list therapies—it delivers options tailored to a patient’s individual disease profile.”

The significance of this tool extends particularly to the 80% of patients who receive care at community oncology centers, where oncologists often juggle multiple cancer types. “This tool can help surface blood cancer treatment options that might otherwise be overlooked in busy practices,” Ahlstrom noted. “When patients understand their treatment choices, they can partner more effectively with their doctors to make informed and optimal care decisions that ultimately get us closer to cures.”

In conclusion, the HealthTree Foundation's Treatment Options Finder is set to revolutionize blood cancer treatment by providing patients with the insights they need to make informed decisions. This innovative approach represents a crucial step forward in the fight against blood cancers, aligning with HealthTree's mission to improve outcomes and accelerate cures through technology, education, and patient empowerment. For further details about this initiative, visit healthtree.org.